TP63 and Patent ductus arteriosus: Whilst this hypothesis is robustly supported in the current study, our in vitro and in vivo studies, together with single cell RNA-seq analysis of PDA patient tumors, suggest that with increasing complexity of the tumor microenvironment, the association of p63 expression in PDA cells with myCAF abundance is more variable.